Skip to main content
Equibles

MORGAN STANLEY

Position in KZIA — Kazia Therapeutics Ltd

CIK 895421 NEW YORK, NY
Back to KZIA Full portfolio

Position in KZIA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$656,212
+$648,772 QoQ
Shares Held
46,606
+4560.6% QoQ
Ownership
0.408%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 35 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 68% Shared 0% None 32%

Common Shares in KZIA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. KZIA ranks #264 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in KZIA

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $656,212 46,606
2026-03-31 $7,440 1,000
2025-12-31 $6,890 1,000
2025-09-30 $1,442 200
2024-12-31 $41,492 23,442
2024-09-30 $94,712 220,261
2024-06-30 $46,248 201,082
2024-03-31 $61,333 197,850
2023-12-31 $88,682 201,550
2023-09-30 $189,950 189,950
2023-06-30 $237,278 204,550
2023-03-31 $205,433 199,450
2022-12-31 $156,978 257,341
2022-09-30 $224,895 204,450
2022-06-30 $846,741 201,605
2022-03-31 $2,261,928 293,376
2021-12-31 $2,521,166 299,426
2021-09-30 $3,252,756 287,346
2021-06-30 $2,306,776 233,953
2021-03-31 $2,861,932 230,801
2020-12-31 $1,551,744 179,600
2020-09-30 $1,018,575 150,900
2020-06-30 $354,933 104,700
2020-03-31 $229,978 79,303